Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant for Prevention of Post-ERCP Pancreatitis
NCT00736073Phase 2Completed
- Sponsor
- Duke University
- Start
- Aug 2007
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pancreatitis comparing Aprepitant with Placebo (2 arms). Primary endpoint: Number of Post-ERCP Pancreatitis Cases at 48 hours. Started Aug 2007; status: completed.
02
Drugs
aprepitant
03
Conditions
pancreatitis
Beyond the preview
Go deeper on NCT00736073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00736073.